|
1
|
Lamptey RNL, Chaulagain B, Trivedi R,
Gothwal A, Layek B and Singh J: A Review of the common
neurodegenerative disorders: Current therapeutic approaches and the
potential role of nanotherapeutics. Int J Mol Sci. 23:18512022.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hou Y, Dan X, Babbar M, Wei Y, Hasselbalch
SG, Croteau DL and Bohr VA: Ageing as a risk factor for
neurodegenerative disease. Nat Rev Neurol. 15:565–581. 2019.
View Article : Google Scholar
|
|
3
|
Scheltens P, De Strooper B, Kivipelto M,
Holstege H, Chetelat G, Teunissen CE, Cummings J and van der Flier
WM: Alzheimer's disease. Lancet. 397:1577–1590. 2021. View Article : Google Scholar
|
|
4
|
Kalia LV and Lang AE: Parkinson's disease.
Lancet. 386:896–912. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Feldman EL, Goutman SA, Petri S, Mazzini
L, Savelieff MG, Shaw PJ and Sobue G: Amyotrophic lateral
sclerosis. Lancet. 400:1363–1380. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Vaquer-Alicea J and Diamond MI:
Propagation of protein aggregation in neurodegenerative diseases.
Annu Rev Biochem. 88:785–810. 2019. View Article : Google Scholar
|
|
7
|
Dugger BN and Dickson DW: Pathology of
neurodegenerative diseases. Cold Spring Harb Perspect Biol.
9:a0280352017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gao C, Jiang J, Tan Y and Chen S:
Microglia in neurodegenerative diseases: Mechanism and potential
therapeutic targets. Signal Transduct Target Ther. 8:3592023.
View Article : Google Scholar :
|
|
9
|
Kent SA and Miron VE: Microglia regulation
of central nervous system myelin health and regeneration. Nat Rev
Immunol. 24:49–63. 2024. View Article : Google Scholar
|
|
10
|
Voet S, Srinivasan S, Lamkanfi M and van
Loo G: Inflammasomes in neuroinflammatory and neurodegenerative
diseases. EMBO Mol Med. 11:e102482019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun N, Victor MB, Park YP, Xiong X,
Scannail AN, Leary N, Prosper S, Viswanathan S, Luna X, Boix CA, et
al: Human microglial state dynamics in Alzheimer's disease
progression. Cell. 186:4386–4403.e29. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yu H, Chang Q, Sun T, He X, Wen L, An J,
Feng J and Zhao Y: Metabolic reprogramming and polarization of
microglia in Parkinson's disease: Role of inflammasome and iron.
Ageing Res Rev. 90:1020322023. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Clarke BE and Patani R: The microglial
component of amyotrophic lateral sclerosis. Brain. 143:3526–3539.
2020. View Article : Google Scholar
|
|
14
|
Billingham LK, Stoolman JS, Vasan K,
Rodriguez AE, Poor TA, Szibor M, Jacobs HT, Reczek CR, Rashidi A,
Zhang P, et al: Mitochondrial electron transport chain is necessary
for NLRP3 inflammasome activation. Nat Immunol. 23:692–704. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang Y, Cella M, Mallinson K, Ulrich JD,
Young KL, Robinette ML, Gilfillan S, Krishnan GM, Sudhakar S,
Zinselmeyer BH, et al: TREM2 lipid sensing sustains the microglial
response in an Alzheimer's disease model. Cell. 160:1061–1071.
2015. View Article : Google Scholar :
|
|
16
|
Zheng Z, Chen M, Feng S, Zhao H, Qu T,
Zhao X, Ruan Q, Li L and Guo J: VDR and deubiquitination control
neuronal oxidative stress and microglial inflammation in
Parkinson's disease. Cell Death Discov. 10:1502024. View Article : Google Scholar
|
|
17
|
Yoon H, Shaw JL, Haigis MC and Greka A:
Lipid metabolism in sickness and in health: Emerging regulators of
lipotoxicity. Mol Cell. 81:3708–3730. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shang C, Su Y, Ma J, Li Z, Wang P, Ma H,
Song J and Zhang Z: Huanshaodan regulates microglial glucose
metabolism reprogramming to alleviate neuroinflammation in AD mice
through mTOR/HIF-1α signaling pathway. Front Pharmacol.
15:14345682024. View Article : Google Scholar
|
|
19
|
Baik SH, Kang S, Lee W, Choi H, Chung S,
Kim JI and Mook-Jung I: A breakdown in metabolic reprogramming
causes microglia dysfunction in Alzheimer's disease. Cell Metab.
30:493–507.e6. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nugent AA, Lin K, van Lengerich B,
Lianoglou S, Przybyla L, Davis SS, Llapashtica C, Wang J, Kim DJ,
Xia D, et al: TREM2 regulates microglial cholesterol metabolism
upon chronic phagocytic challenge. Neuron. 105:837–854.e9. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chausse B, Kakimoto PA and Kann O:
Microglia and lipids: How metabolism controls brain innate
immunity. Semin Cell Dev Biol. 112:137–144. 2021. View Article : Google Scholar
|
|
22
|
Lull ME and Block ML: Microglial
activation and chronic neurodegeneration. Neurotherapeutics.
7:354–365. 2010. View Article : Google Scholar
|
|
23
|
Fernando KKM and Wijayasinghe YS: Sirtuins
as potential therapeutic targets for mitigating neuroinflammation
associated with Alzheimer's disease. Front Cell Neurosci.
15:7466312021. View Article : Google Scholar
|
|
24
|
Licata L, Viale G, Giuliano M, Cur igliano
G, Chavez-MacGregor M, Foldi J, Oke O, Collins J, Del Mastro L,
Puglisi F, et al: Oncotype DX results increase concordance in
adjuvant chemotherapy recommendations for early-stage breast
cancer. NPJ Breast Cancer. 9:512023. View Article : Google Scholar :
|
|
25
|
Weiss F, Hughes L, Fu Y, Bardy C, Halliday
GM and Dzamko N: Astrocytes contribute to toll-like receptor
2-mediated neurodegeneration and alpha-synuclein pathology in a
human midbrain Parkinson's model. Transl Neurodegener. 13:622024.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sun L, Jiang WW, Wang Y, Yuan YS, Rong Z,
Wu J, Fan Y, Lu M and Zhang KZ: Phosphorylated α-synuclein
aggregated in Schwann cells exacerbates peripheral
neuroinflammation and nerve dysfunction in Parkinson's disease
through TLR2/NF-κB pathway. Cell Death Discov. 7:2892021.
View Article : Google Scholar
|
|
27
|
Wendimu MY and Hooks SB: Microglia
phenotypes in aging and neurodegenerative diseases. Cells.
11:20192022. View Article : Google Scholar
|
|
28
|
Kettenmann H, Kirchhoff F and Verkhratsky
A: Microglia: New roles for the synaptic stripper. Neuron.
77:10–18. 2013. View Article : Google Scholar
|
|
29
|
Platanitis E and Decker T: Regulatory
networks involving STATs, IRFs, and NFκB in inflammation. Front
Immunol. 9:25422018. View Article : Google Scholar
|
|
30
|
Stewart CR, Stuart LM, Wilkinson K, van
Gils JM, Deng J, Halle A, Rayner KJ, Boyer L, Zhong R, Frazier WA,
et al: CD36 ligands promote sterile inflammation through assembly
of a Toll-like receptor 4 and 6 heterodimer. Nat Immunol.
11:155–161. 2010. View Article : Google Scholar :
|
|
31
|
Wang Y, Wang YC and Ma J: Effects of
electroacupuncture on Sirt3/NLRP3/GSDMD signaling pathway in the
substantia nigra of midbrain of rats with Parkinson's disease. Zhen
Ci Yan Jiu. 49:384–390. 2024.In Chinese.
|
|
32
|
Yu CH, Davidson S, Harapas CR, Hilton JB,
Mlodzianoski MJ, Laohamonthonkul P, Louis C, Low RRJ, Moecking J,
De Nardo D, et al: TDP-43 triggers mitochondrial DNA release via
mPTP to activate cGAS/STING in ALS. Cell. 183:636–649.e18. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Becker LA, Huang B, Bieri G, Ma R, Knowles
DA, Jafar-Nejad P, Messing J, Kim HJ, Soriano A, Auburger G, et al:
Therapeutic reduction of ataxin-2 extends lifespan and reduces
pathology in TDP-43 mice. Nature. 544:367–371. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Deane R, Singh I, Sagare AP, Bell RD, Ross
NT, LaRue B, Love R, Perry S, Paquette N, Deane RJ, et al: A
multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain
disorder in a mouse model of Alzheimer disease. J Clin Invest.
122:1377–1392. 2012. View Article : Google Scholar :
|
|
35
|
Hanslik KL and Ulland TK: The role of
microglia and the Nlrp3 inflammasome in Alzheimer's disease. Front
Neurol. 11:5707112020. View Article : Google Scholar :
|
|
36
|
Bolos M, Llorens-Martin M, Perea JR,
Jurado-Arjona J, Rabano A, Hernandez F and Avila J: Absence of
CX3CR1 impairs the internalization of Tau by microglia. Mol
Neurodegener. 12:592017. View Article : Google Scholar :
|
|
37
|
Chidambaram H, Das R and Chinnathambi S:
Interaction of Tau with the chemokine receptor, CX3CR1 and its
effect on microglial activation, migration and proliferation. Cell
Biosci. 10:1092020. View Article : Google Scholar
|
|
38
|
Wilton DK, Mastro K, Heller MD, Gergits
FW, Willing CR, Fahey JB, Frouin A, Daggett A, Gu X, Kim YA, et al:
Microglia and complement mediate early corticostriatal synapse loss
and cognitive dysfunction in Huntington's disease. Nat Med.
29:2866–2884. 2023. View Article : Google Scholar
|
|
39
|
Hong S, Beja-Glasser VF, Nfonoyim BM,
Frouin A, Li S, Ramakrishnan S, Merry KM, Shi Q, Rosenthal A,
Barres BA, et al: Complement and microglia mediate early synapse
loss in Alzheimer mouse models. Science. 352:712–716. 2016.
View Article : Google Scholar :
|
|
40
|
Kim A, Garcia-Garcia E, Straccia M,
Comella-Bolla A, Miguez A, Masana M, Alberch J, Canals JM and
Rodriguez MJ: Reduced fractalkine levels lead to striatal synaptic
plasticity deficits in Huntington's disease. Front Cell Neurosci.
14:1632020. View Article : Google Scholar
|
|
41
|
Logan T, Simon MJ, Rana A, Cherf GM,
Srivastava A, Davis SS, Low RLY, Chiu CL, Fang M, Huang F, et al:
Rescue of a lysosomal storage disorder caused by Grn loss of
function with a brain penetrant progranulin biologic. Cell.
184:4651–4668.e25. 2021. View Article : Google Scholar
|
|
42
|
Mata-Martinez E, Diaz-Munoz M and
Vazquez-Cuevas FG: Glial cells and brain diseases: Inflammasomes as
relevant pathological entities. Front Cell Neurosci. 16:9295292022.
View Article : Google Scholar :
|
|
43
|
Xu P, Zhang X, Liu Q, Xie Y, Shi X, Chen
J, Li Y, Guo H, Sun R, Hong Y, et al: Microglial TREM-1 receptor
mediates neuroinflammatory injury via interaction with SYK in
experimental ischemic stroke. Cell Death Dis. 10:5552019.
View Article : Google Scholar :
|
|
44
|
Qin Q, Teng Z, Liu C, Li Q, Yin Y and Tang
Y: TREM2, microglia, and Alzheimer's disease. Mech Ageing Dev.
195:1114382021. View Article : Google Scholar
|
|
45
|
Caldeira C, Cunha C, Vaz AR, Falcao AS,
Barateiro A, Seixas E, Fernandes A and Brites D: Key
Aging-associated alterations in primary microglia response to
Beta-amyloid stimulation. Front Aging Neurosci. 9:2772017.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Condello C, Yuan P, Schain A and
Grutzendler J: Microglia Constitute a barrier that prevents
neurotoxic protofibrillar Aβ42 hotspots around plaques. Nat Commun.
6:61762015. View Article : Google Scholar
|
|
47
|
Feng W, Zhang Y, Wang Z, Xu H, Wu T,
Marshall C, Gao J and Xiao M: Microglia Prevent beta-amyloid plaque
formation in the early stage of an Alzheimer's disease mouse model
with suppression of glymphatic clearance. Alzheimers Res Ther.
12:1252020. View Article : Google Scholar
|
|
48
|
Krasemann S, Madore C, Cialic R, Baufeld
C, Calcagno N, El Fatimy R, Beckers L, O'Loughlin E, Xu Y, Fanek Z,
et al: The TREM2-APOE pathway drives the transcriptional phenotype
of dysfunctional microglia in neurodegenerative diseases. Immunity.
47:566–581.e9. 2017. View Article : Google Scholar :
|
|
49
|
Felsky D, Patrick E, Schneider JA,
Mostafavi S, Gaiteri C, Patsopoulos N, Bennett DA and De Jager PL:
Polygenic analysis of inflammatory disease variants and effects on
microglia in the aging brain. Mol Neurodegener. 13:382018.
View Article : Google Scholar
|
|
50
|
Absinta M, Maric D, Gharagozloo M, Garton
T, Smith MD, Jin J, Fitzgerald KC, Song A, Liu P, Lin JP, et al: A
lymphocyte-microglia-astrocyte axis in chronic active multiple
sclerosis. Nature. 597:709–714. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Werneburg S, Jung J, Kunjamma RB, Ha SK,
Luciano NJ, Willis CM, Gao G, Biscola NP, Havton LA, Crocker SJ, et
al: Targeted complement inhibition at synapses prevents microglial
synaptic engulfment and synapse loss in demyelinating disease.
Immunity. 52:167–182.e7. 2020. View Article : Google Scholar :
|
|
52
|
Ellrichmann G, Reick C, Saft C and Linker
RA: The role of the immune system in Huntington's disease. Clin Dev
Immunol. 2013:5412592013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Creus-Muncunill J and Ehrlich ME:
Cell-Autonomous and Non-cell-autonomous pathogenic mechanisms in
Huntington's disease: Insights from in vitro and in vivo models.
Neurotherapeutics. 16:957–978. 2019. View Article : Google Scholar
|
|
54
|
Udeochu JC, Amin S, Huang Y, Fan L, Torres
ERS, Carling GK, Liu B, McGurran H, Coronas-Samano G, Kauwe G, et
al: Tau activation of microglial cGAS-IFN reduces MEF2C-mediated
cognitive resilience. Nat Neurosci. 26:737–750. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Hu Y, Fryatt GL, Ghorbani M, Obst J,
Menassa DA, Martin-Estebane M, Muntslag TAO, Olmos-Alonso A,
Guerrero-Carrasco M, Thomas D, et al: Replicative senescence
dictates the emergence of disease-associated microglia and
contributes to Aβ pathology. Cell Rep. 35:1092282021. View Article : Google Scholar
|
|
56
|
Yamamoto M, Kiyota T, Walsh SM, Liu J,
Kipnis J and Ikezu T: Cytokine-mediated inhibition of fibrillar
amyloid-beta peptide degradation by human mononuclear phagocytes. J
Immunol. 181:3877–3886. 2008. View Article : Google Scholar
|
|
57
|
Han F, Perrin RJ, Wang Q, Wang Y,
Perlmutter JS, Morris JC, Benzinger TLS and Xu J: Neuroinflammation
and Myelin Status in Alzheimer's disease, Parkinson's disease, and
normal aging brains: A small sample study. Parkinsons Dis.
2019:79754072019.PubMed/NCBI
|
|
58
|
Jurga AM, Paleczna M and Kuter KZ:
Overview of general and discriminating markers of differential
microglia phenotypes. Front Cell Neurosci. 14:1982020. View Article : Google Scholar :
|
|
59
|
Gadani SP, Cronk JC, Norris GT and Kipnis
J: IL-4 in the brain: A cytokine to remember. J Immunol.
189:4213–4219. 2012. View Article : Google Scholar
|
|
60
|
Liddelow SA, Guttenplan KA, Clarke LE,
Bennett FC, Bohlen CJ, Schirmer L, Bennett ML, Munch AE, Chung WS,
Peterson TC, et al: Neurotoxic reactive astrocytes are induced by
activated microglia. Nature. 541:481–487. 2017. View Article : Google Scholar
|
|
61
|
Tecchio C, Micheletti A and Cassatella MA:
Neutrophil-derived cytokines: Facts beyond expression. Front
Immunol. 5:5082014. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Kummer MP, Hermes M, Delekarte A,
Hammerschmidt T, Kumar S, Terwel D, Walter J, Pape HC, König S,
Roeber S, et al: Nitration of tyrosine 10 critically enhances
amyloid β aggregation and plaque formation. Neuron. 71:833–844.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Wang WY, Tan MS, Yu JT and Tan L: Role of
pro-inflammatory cytokines released from microglia in Alzheimer's
disease. Ann Transl Med. 3:1362015.PubMed/NCBI
|
|
64
|
Sheffield LG, Marquis JG and Berman NE:
Regional distribution of cortical microglia parallels that of
neurofibrillary tangles in Alzheimer's disease. Neurosci Lett.
285:165–168. 2000. View Article : Google Scholar
|
|
65
|
Venegas C and Heneka MT: Danger-associated
molecular patterns in Alzheimer's disease. J Leukoc Biol.
101:87–98. 2017. View Article : Google Scholar
|
|
66
|
Jha MK, Jo M, Kim JH and Suk K:
Microglia-astrocyte crosstalk: An intimate molecular conversation.
Neuroscientist. 25:227–240. 2019. View Article : Google Scholar
|
|
67
|
Hanisch UK and Kettenmann H: Microglia:
Active sensor and versatile effector cells in the normal and
pathologic brain. Nat Neurosci. 10:1387–1394. 2007. View Article : Google Scholar
|
|
68
|
Valdearcos M, Douglass JD, Robblee MM,
Dorfman MD, Stifler DR, Bennett ML, Gerritse I, Fasnacht R, Barres
BA, Thaler JP and Koliwad SK: Microglial inflammatory signaling
orchestrates the hypothalamic immune response to dietary excess and
mediates obesity susceptibility. Cell Metab. 26:185–197.e3. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Doens D and Fernandez PL: Microglia
receptors and their implications in the response to amyloid β for
Alzheimer's disease pathogenesis. J Neuroinflammation. 11:482014.
View Article : Google Scholar
|
|
70
|
Kim E, Tolhurst AT, Qin LY, Chen XY,
Febbraio M and Cho S: CD36/fatty acid translocase, an inflammatory
mediator, is involved in hyperlipidemia-induced exacerbation in
ischemic brain injury. J Neurosci. 28:4661–4670. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Gao D, Ashraf MZ, Kar NS, Lin D, Sayre LM
and Podrez EA: Structural basis for the recognition of oxidized
phospholipids in oxidized low density lipoproteins by class B
scavenger receptors CD36 and SR-BI. J Biol Chem. 285:4447–4454.
2010. View Article : Google Scholar :
|
|
72
|
Coraci IS, Husemann J, Berman JW, Hulette
C, Dufour JH, Campanella GK, Luster AD, Silverstein SC and
El-Khoury JB: CD36, a class B scavenger receptor, is expressed on
microglia in Alzheimer's disease brains and can mediate production
of reactive oxygen species in response to beta-amyloid fibrils. Am
J Pathol. 160:101–112. 2002. View Article : Google Scholar
|
|
73
|
Yamanaka M, Ishikawa T, Griep A, Axt D,
Kummer MP and Heneka MT: PPARγ/RXRα-induced and CD36-mediated
microglial amyloid-β phagocytosis results in cognitive improvement
in amyloid precursor protein/presenilin 1 mice. J Neurosci.
32:17321–17331. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Sheedy FJ, Grebe A, Rayner KJ, Kalantari
P, Ramkhelawon B, Carpenter SB, Becker CE, Ediriweera HN, Mullick
AE, Golenbock DT, et al: CD36 coordinates NLRP3 inflammasome
activation by facilitating intracellular nucleation of soluble
ligands into particulate ligands in sterile inflammation. Nat
Immunol. 14:812–820. 2013. View Article : Google Scholar :
|
|
75
|
Cantuti-Castelvetri L, Fitzner D,
Bosch-Queralt M, Weil MT, Su M, Sen P, Ruhwedel T, Mitkovski M,
Trendelenburg G, Lütjohann D, et al: Defective cholesterol
clearance limits remyelination in the aged central nervous system.
Science. 359:684–688. 2018. View Article : Google Scholar
|
|
76
|
Yeh FL, Wang Y, Tom I, Gonzalez LC and
Sheng M: TREM2 binds to apolipoproteins, including APOE and
CLU/APOJ, and thereby facilitates uptake of Amyloid-beta by
microglia. Neuron. 91:328–340. 2016. View Article : Google Scholar
|
|
77
|
Lessard CB, Malnik SL, Zhou Y, Ladd TB,
Cruz PE, Ran Y, Mahan TE, Chakrabaty P, Holtzman DM, Ulrich JD, et
al: High-affinity interactions and signal transduction between Aβ
oligomers and TREM2. EMBO Mol Med. 10:e90272018. View Article : Google Scholar
|
|
78
|
Beisiegel U, Weber W and
Bengtsson-Olivecrona G: Lipoprotein lipase enhances the binding of
chylomicrons to low density lipoprotein receptor-related protein.
Proc Natl Acad Sci USA. 88:8342–8346. 1991. View Article : Google Scholar
|
|
79
|
Gao Y, Vidal-Itriago A, Kalsbeek MJ,
Layritz C, Garcia-Caceres C, Tom RZ, Eichmann TO, Vaz FM,
Houtkooper RH, Van der Wel N, et al: Lipoprotein lipase maintains
microglial innate immunity in obesity. Cell Rep. 20:3034–3042.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Aflaki E, Radovic B, Chandak PG, Kolb D,
Eisenberg T, Ring J, Fertschai I, Uellen A, Wolinski H, Kohlwein
SD, et al: Triacylglycerol accumulation activates the mitochondrial
apoptosis pathway in macrophages. J Biol Chem. 286:7418–7428. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Weinger JG, Brosnan CF, Loudig O, Goldberg
MF, Macian F, Arnett HA, Prieto AL, Tsiperson V and Shafit-Zagardo
B: Loss of the receptor tyrosine kinase Axl leads to enhanced
inflammation in the CNS and delayed removal of myelin debris during
experimental autoimmune encephalomyelitis. J Neuroinflammation.
8:492011. View Article : Google Scholar :
|
|
82
|
Shirotani K, Hori Y, Yoshizaki R, Higuchi
E, Colonna M, Saito T, Hashimoto S, Saito T, Saido TC and Iwata N:
Aminophospholipids are Signal-transducing TREM2 ligands on
apoptotic cells. Sci Rep. 9:75082019. View Article : Google Scholar :
|
|
83
|
Bogie JF, Jorissen W, Mailleux J, Nijland
PG, Zelcer N, Vanmierlo T, Van Horssen J, Stinissen P, Hellings N
and Hendriks JJ: Myelin alters the inflammatory phenotype of
macrophages by activating PPARs. Acta Neuropathol Commun. 1:432013.
View Article : Google Scholar
|
|
84
|
Bogie JF, Timmermans S, Huynh-Thu VA,
Irrthum A, Smeets HJ, Gustafsson JA, Steffensen KR, Mulder M,
Stinissen P, Hellings N and Hendriks JJ: Myelin-derived lipids
modulate macrophage activity by liver X receptor activation. PLoS
One. 7:e449982012. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Safaiyan S, Kannaiyan N, Snaidero N,
Brioschi S, Biber K, Yona S, Edinger AL, Jung S, Rossner MJ and
Simons M: Age-related myelin degradation burdens the clearance
function of microglia during aging. Nat Neurosci. 19:995–998. 2016.
View Article : Google Scholar
|
|
86
|
Gabande-Rodriguez E, Perez-Canamas A,
Soto-Huelin B, Mitroi DN, Sanchez-Redondo S, Martinez-Saez E,
Venero C, Peinado H and Ledesma MD: Lipid-induced lysosomal damage
after demyelination corrupts microglia protective function in
lysosomal storage disorders. EMBO J. 38:e995532019. View Article : Google Scholar
|
|
87
|
Carta AR and Simuni T: Thiazolidinediones
under preclinical and early clinical development for the treatment
of Parkinson's disease. Expert Opin Investig Drugs. 24:219–227.
2015. View Article : Google Scholar
|
|
88
|
Pioglitazone in early Parkinson's disease:
A phase 2, multicentre, double-blind, randomised trial. Lancet
Neurol. 14:795–803. 2015. View Article : Google Scholar
|
|
89
|
Huyghe S, Mannaerts GP, Baes M and Van
Veldhoven PP: Peroxisomal multifunctional protein-2: The enzyme,
the patients and the knockout mouse model. Biochim Biophys Acta.
1761:973–994. 2006. View Article : Google Scholar
|
|
90
|
Gong Y, Sasidharan N, Laheji F, Frosch M,
Musolino P, Tanzi R, Kim DY, Biffi A, El Khoury J and Eichler F:
Microglial dysfunction as a key pathological change in
adrenomyeloneuropathy. Ann Neurol. 82:813–827. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Beckers L, Geric I, Stroobants S, Beel S,
Van Damme P, D'Hooge R and Baes M: Microglia lacking a peroxisomal
β-oxidation enzyme chronically alter their inflammatory profile
without evoking neuronal and behavioral deficits. J
Neuroinflammation. 16:612019. View Article : Google Scholar
|
|
92
|
Verheijden S, Beckers L, Casazza A,
Butovsky O, Mazzone M and Baes M: Identification of a chronic
non-neurodegenerative microglia activation state in a mouse model
of peroxisomal β-oxidation deficiency. Glia. 63:1606–1620. 2015.
View Article : Google Scholar
|
|
93
|
Sangineto M, Ciarnelli M, Cassano T,
Radesco A, Moola A, Bukke VN, Romano A, Villani R, Kanwal H,
Capitanio N, et al: Metabolic reprogramming in inflammatory
microglia indicates a potential way of targeting inflammation in
Alzheimer's disease. Redox Biol. 66:1028462023. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Meiser J, Kramer L, Sapcariu SC, Battello
N, Ghelfi J, D'Herouel AF, Skupin A and Hiller K: Pro-inflammatory
macrophages sustain pyruvate oxidation through pyruvate
dehydrogenase for the synthesis of itaconate and to enable cytokine
expression. J Biol Chem. 291:3932–3946. 2016. View Article : Google Scholar :
|
|
95
|
Lauterbach MA, Hanke JE, Serefidou M,
Mangan MSJ, Kolbe CC, Hess T, Rothe M, Kaiser R, Hoss F, Gehlen J,
et al: Toll-like receptor signaling rewires macrophage metabolism
and promotes histone acetylation via ATP-citrate lyase. Immunity.
51:997–1011.e7. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Plastira I, Bernhart E, Joshi L, Koyani
CN, Strohmaier H, Reicher H, Malle E and Sattler W: MAPK signaling
determines lysophosphatidic acid (LPA)-induced inflammation in
microglia. J Neuroinflammation. 17:1272020. View Article : Google Scholar :
|
|
97
|
Huang YL, Morales-Rosado J, Ray J, Myers
TG, Kho T, Lu M and Munford RS: Toll-like receptor agonists promote
prolonged triglyceride storage in macrophages. J Biol Chem.
289:3001–3012. 2014. View Article : Google Scholar :
|
|
98
|
Palmieri EM, Gonzalez-Cotto M, Baseler WA,
Davies LC, Ghesquiere B, Maio N, Rice CM, Rouault TA, Cassel T,
Higashi RM, et al: Nitric oxide orchestrates metabolic rewiring in
M1 macrophages by targeting aconitase 2 and pyruvate dehydrogenase.
Nat Commun. 11:6982020. View Article : Google Scholar
|
|
99
|
Rosas-Ballina M, Guan XL, Schmidt A and
Bumann D: Classical activation of macrophages leads to lipid
droplet formation without de novo fatty acid synthesis. Front
Immunol. 11:1312020. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Bailey AP, Koster G, Guillermier C, Hirst
EM, MacRae JI, Lechene CP, Postle AD and Gould AP: Antioxidant role
for lipid droplets in a stem cell niche of drosophila. Cell.
163:340–353. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Khatchadourian A, Bourque SD, Richard VR,
Titorenko VI and Maysinger D: Dynamics and regulation of lipid
droplet formation in lipopolysaccharide (LPS)-stimulated microglia.
Biochim Biophys Acta. 1821:607–617. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Marschallinger J, Iram T, Zardeneta M, Lee
SE, Lehallier B, Haney MS, Pluvinage JV, Mathur V, Hahn O, Morgens
DW, et al: Lipid-droplet-accumulating microglia represent a
dysfunctional and proinflammatory state in the aging brain. Nat
Neurosci. 23:194–208. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Bogie JFJ, Grajchen E, Wouters E, Corrales
AG, Dierckx T, Vanherle S, Mailleux J, Gervois P, Wolfs E, Dehairs
J, et al: Stearoyl-CoA desaturase-1 impairs the reparative
properties of macrophages and microglia in the brain. J Exp Med.
217:e201916602020. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Szatmari I, Torocsik D, Agostini M, Nagy
T, Gurnell M, Barta E, Chatterjee K and Nagy L: PPARgamma regulates
the function of human dendritic cells primarily by altering lipid
metabolism. Blood. 110:3271–3280. 2007. View Article : Google Scholar
|
|
105
|
Schonfeld P and Reiser G: Brain energy
metabolism spurns fatty acids as fuel due to their inherent
mitotoxicity and potential capacity to unleash neurodegeneration.
Neurochem Int. 109:68–77. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Li LO, Klett EL and Coleman RA: Acyl-CoA
synthesis, lipid metabolism and lipotoxicity. Biochim Biophys Acta.
1801:246–251. 2010. View Article : Google Scholar :
|
|
107
|
Fonteh AN, Cipolla M, Chiang J, Arakaki X
and Harrington MG: Human cerebrospinal fluid fatty acid levels
differ between supernatant fluid and brain-derived nanoparticle
fractions, and are altered in Alzheimer's disease. PLoS One.
9:e1005192014. View Article : Google Scholar
|
|
108
|
Cunnane SC, Schneider JA, Tangney C,
Tremblay-Mercier J, Fortier M, Bennett DA and Morris MC: Plasma and
brain fatty acid profiles in mild cognitive impairment and
Alzheimer's disease. J Alzheimers Dis. 29:691–697. 2012. View Article : Google Scholar
|
|
109
|
Snowden SG, Ebshiana AA, Hye A, An Y,
Pletnikova O, O'Brien R, Troncoso J, Legido-Quigley C and
Thambisetty M: Association between fatty acid metabolism in the
brain and Alzheimer disease neuropathology and cognitive
performance: A nontargeted metabolomic study. PLoS Med.
14:e10022662017. View Article : Google Scholar :
|
|
110
|
Belkouch M, Hachem M, Elgot A, Lo Van A,
Picq M, Guichardant M, Lagarde M and Bernoud-Hubac N: The
pleiotropic effects of omega-3 docosahexaenoic acid on the
hallmarks of Alzheimer's disease. J Nutr Biochem. 38:1–11. 2016.
View Article : Google Scholar
|
|
111
|
Fonteh AN, Cipolla M, Chiang AJ, Edminster
SP, Arakaki X and Harrington MG: Polyunsaturated fatty acid
composition of cerebrospinal fluid fractions shows their
contribution to cognitive resilience of a Pre-symptomatic
Alzheimer's disease cohort. Front Physiol. 11:832020. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Prasad MR, Lovell MA, Yatin M, Dhillon H
and Markesbery WR: Regional membrane phospholipid alterations in
Alzheimer's disease. Neurochem Res. 23:81–88. 1998. View Article : Google Scholar
|
|
113
|
Sebastiao AM, Colino-Oliveira M,
Assaife-Lopes N, Dias RB and Ribeiro JA: Lipid rafts, synaptic
transmission and plasticity: Impact in Age-related
neurodegenerative diseases. Neuropharmacology. 64:97–107. 2013.
View Article : Google Scholar
|
|
114
|
Sezgin E, Levental I, Mayor S and Eggeling
C: The mystery of membrane organization: Composition, regulation
and roles of lipid rafts. Nat Rev Mol Cell Biol. 18:361–374. 2017.
View Article : Google Scholar :
|
|
115
|
Martin V, Fabelo N, Santpere G, Puig B,
Marin R, Ferrer I and Diaz M: Lipid alterations in lipid rafts from
Alzheimer's disease human brain cortex. J Alzheimers Dis.
19:489–502. 2010. View Article : Google Scholar
|
|
116
|
Fabelo N, Martin V, Marin R, Moreno D,
Ferrer I and Diaz M: Altered lipid composition in cortical lipid
rafts occurs at early stages of sporadic Alzheimer's disease and
facilitates APP/BACE1 interactions. Neurobiol Aging. 35:1801–1812.
2014. View Article : Google Scholar
|
|
117
|
Filippov V, Song MA, Zhang K, Vinters HV,
Tung S, Kirsch WM, Yang J and Duerksen-Hughes PJ: Increased
ceramide in brains with Alzheimer's and other neurodegenerative
diseases. J Alzheimers Dis. 29:537–547. 2012. View Article : Google Scholar
|
|
118
|
Cutler RG, Kelly J, Storie K, Pedersen WA,
Tammara A, Hatanpaa K, Troncoso JC and Mattson MP: Involvement of
oxidative Stress-induced abnormalities in ceramide and cholesterol
metabolism in brain aging and Alzheimer's disease. Proc Natl Acad
Sci USA. 101:2070–2075. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Han X, M Holtzman D, McKeel DW Jr, Kelley
J and Morris JC: Substantial sulfatide deficiency and ceramide
elevation in very early Alzheimer's disease: Potential role in
disease pathogenesis. J Neurochem. 82:809–818. 2002. View Article : Google Scholar
|
|
120
|
He X, Huang Y, Li B, Gong CX and Schuchman
EH: Deregulation of sphingolipid metabolism in Alzheimer's disease.
Neurobiol Aging. 31:398–408. 2010. View Article : Google Scholar :
|
|
121
|
Soderberg M, Edlund C, Alafuzoff I,
Kristensson K and Dallner G: Lipid composition in different regions
of the brain in Alzheimer's disease/senile dementia of Alzheimer's
type. J Neurochem. 59:1646–1653. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Siskind LJ: Mitochondrial ceramide and the
induction of apoptosis. J Bioenerg Biomembr. 37:143–153. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Morris MC, Evans DA, Bienias JL, Tangney
CC, Bennett DA, Wilson RS, Aggarwal N and Schneider J: Consumption
of fish and n-3 fatty acids and risk of incident Alzheimer disease.
Arch Neurol. 60:940–946. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Grimm MO, Grimm HS, Pätzold AJ, Zinser EG,
Halonen R, Duering M, Tschape JA, De Strooper B, Müller U, Shen J
and Hartmann T: Regulation of cholesterol and sphingomyelin
metabolism by amyloid-beta and presenilin. Nat Cell Biol.
7:1118–1123. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Cheng H, Wang M, Li JL, Cairns NJ and Han
X: Specific changes of sulfatide levels in individuals with
pre-clinical Alzheimer's disease: An early event in disease
pathogenesis. J Neurochem. 127:733–738. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Couttas TA, Kain N, Suchowerska AK, Quek
LE, Turner N, Fath T, Garner B and Don AS: Loss of ceramide
synthase 2 activity, necessary for myelin biosynthesis, precedes
tau pathology in the cortical pathogenesis of Alzheimer's disease.
Neurobiol Aging. 43:89–100. 2016. View Article : Google Scholar
|
|
127
|
Nasrabady SE, Rizvi B, Goldman JE and
Brickman AM: White matter changes in Alzheimer's disease: A focus
on myelin and oligodendrocytes. Acta Neuropathol Commun. 6:222018.
View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Heverin M, Bogdanovic N, Lutjohann D,
Bayer T, Pikuleva I, Bretillon L, Diczfalusy U, Winblad B and
Bjorkhem I: Changes in the levels of cerebral and extracerebral
sterols in the brain of patients with Alzheimer's disease. J Lipid
Res. 45:186–193. 2004. View Article : Google Scholar
|
|
129
|
Popp J, Meichsner S, Kolsch H, Lewczuk P,
Maier W, Kornhuber J, Jessen F and Lutjohann D: Cerebral and
extracerebral cholesterol metabolism and CSF markers of Alzheimer's
disease. Biochem Pharmacol. 86:37–42. 2013. View Article : Google Scholar
|
|
130
|
Liu Y, Zhong X, Shen J, Jiao L, Tong J,
Zhao W, Du K, Gong S, Liu M and Wei M: Elevated serum TC and LDL-C
levels in Alzheimer's disease and mild cognitive impairment: A
meta-analysis study. Brain Res. 1727:1465542020. View Article : Google Scholar
|
|
131
|
Zhang J and Liu Q: Cholesterol metabolism
and homeostasis in the brain. Protein Cell. 6:254–264. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Tajima Y, Ishikawa M, Maekawa K, Murayama
M, Senoo Y, Nishimaki-Mogami T, Nakanishi H, Ikeda K, Arita M and
Taguchi R: Lipidomic analysis of brain tissues and plasma in a
mouse model expressing mutated human amyloid precursor protein/tau
for Alzheimer's disease. Lipids Health Dis. 12:682013. View Article : Google Scholar
|
|
133
|
Bhattacharyya R, Barren C and Kovacs DM:
Palmitoylation of amyloid precursor protein regulates amyloidogenic
processing in lipid rafts. J Neurosci. 33:11169–11183. 2013.
View Article : Google Scholar :
|
|
134
|
Wang H, Kulas JA, Wang C, Holtzman DM,
Ferris HA and Hansen SB: Regulation of beta-amyloid production in
neurons by astrocyte-derived cholesterol. Proc Natl Acad Sci USA.
118:e21021911182021. View Article : Google Scholar
|
|
135
|
Qi G, Mi Y, Shi X, Gu H, Brinton RD and
Yin F: ApoE4 impairs Neuron-astrocyte coupling of fatty acid
metabolism. Cell Rep. 34:1085722021. View Article : Google Scholar :
|
|
136
|
Zhao J, Davis MD, Martens YA, Shinohara M,
Graff-Radford NR, Younkin SG, Wszolek ZK, Kanekiyo T and Bu G: APOE
ε4/ε4 diminishes neurotrophic function of human iPSC-derived
astrocytes. Hum Mol Genet. 26:2690–2700. 2017. View Article : Google Scholar
|
|
137
|
Kober DL and Brett TJ: TREM2-ligand
interactions in health and disease. J Mol Biol. 429:1607–1629.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Gouna G, Klose C, Bosch-Queralt M, Liu L,
Gokce O, Schifferer M, Cantuti-Castelvetri L and Simons M:
TREM2-dependent lipid droplet biogenesis in phagocytes is required
for remyelination. J Exp Med. 218:e202102272021. View Article : Google Scholar :
|
|
139
|
Basil MC and Levy BD: Specialized
Pro-resolving mediators: Endogenous regulators of infection and
inflammation. Nat Rev Immunol. 16:51–67. 2016. View Article : Google Scholar
|
|
140
|
Whittington RA, Planel E and Terrando N:
Impaired resolution of inflammation in Alzheimer's disease: A
review. Front Immunol. 8:14642017. View Article : Google Scholar
|
|
141
|
Emre C, Hjorth E, Bharani K, Carroll S,
Granholm AC and Schultzberg M: Receptors for Pro-resolving
mediators are increased in Alzheimer's disease brain. Brain Pathol.
30:614–640. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Zhu M, Wang X, Hjorth E, Colas RA,
Schroeder L, Granholm AC, Serhan CN and Schultzberg M:
Pro-resolving lipid mediators improve neuronal survival and
increase Aβ42 phagocytosis. Mol Neurobiol. 53:2733–2749. 2016.
View Article : Google Scholar
|
|
143
|
Wang X, Zhu M, Hjorth E, Cortes-Toro V,
Eyjolfsdottir H, Graff C, Nennesmo I, Palmblad J, Eriksdotter M, et
al: Resolution of inflammation is altered in Alzheimer's disease.
Alzheimers Dement. 11:40–50. e1–e2. 2015. View Article : Google Scholar
|
|
144
|
Malaplate-Armand C, Florent-Bechard S,
Youssef I, Koziel V, Sponne I, Kriem B, Leininger-Muller B, Olivier
JL, Oster T and Pillot T: Soluble oligomers of amyloid-beta peptide
induce neuronal apoptosis by activating a cPLA2-dependent
sphingomyelinase-ceramide pathway. Neurobiol Dis. 23:178–189. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Prasad VV, Nithipatikom K and Harder DR:
Ceramide elevates 12-hydroxyeicosatetraenoic acid levels and
upregulates 12-lipoxygenase in rat primary hippocampal cell
cultures containing predominantly astrocytes. Neurochem Int.
53:220–229. 2008. View Article : Google Scholar
|
|
146
|
Assayag K, Yakunin E, Loeb V, Selkoe DJ
and Sharon R: Polyunsaturated fatty acids induce
alpha-synuclein-related pathogenic changes in neuronal cells. Am J
Pathol. 171:2000–2011. 2007. View Article : Google Scholar
|
|
147
|
Flores-Leon M and Outeiro TF: More than
meets the eye in Parkinson's disease and other synucleinopathies:
From proteinopathy to lipidopathy. Acta Neuropathol. 146:369–385.
2023. View Article : Google Scholar
|
|
148
|
Yakunin E, Loeb V, Kisos H, Biala Y,
Yehuda S, Yaari Y, Selkoe DJ and Sharon R: Α-synuclein
neuropathology is controlled by nuclear hormone receptors and
enhanced by docosahexaenoic acid in a mouse model for Parkinson's
disease. Brain Pathol. 22:280–294. 2012. View Article : Google Scholar
|
|
149
|
Galvagnion C: The role of lipids
interacting with α-synuclein in the pathogenesis of Parkinson's
disease. J Parkinsons Dis. 7:433–450. 2017. View Article : Google Scholar
|
|
150
|
Garcia-Sanz P, MFG Aerts J and Moratalla
R: The role of cholesterol in alpha-synuclein and lewy body
pathology in GBA1 Parkinson's disease. Mov Disord. 36:1070–1085.
2021. View Article : Google Scholar
|
|
151
|
Paslawski W, Zareba-Paslawska J, Zhang X,
Holzl K, Wadensten H, Shariatgorji M, Janelidze S, Hansson O,
Forsgren L, Andrén PE and Svenningsson P: α-synuclein-lipoprotein
interactions and elevated ApoE level in cerebrospinal fluid from
Parkinson's disease patients. Proc Natl Acad Sci USA.
116:15226–15235. 2019. View Article : Google Scholar
|
|
152
|
Kim HE, Grant AR, Simic MS, Kohnz RA,
Nomura DK, Durieux J, Riera CE, Sanchez M, Kapernick E, Wolff S and
Dillin A: Lipid biosynthesis coordinates a
mitochondrial-to-Cytosolic stress response. Cell.
166:1539–1552.e16. 2016. View Article : Google Scholar
|
|
153
|
Stein D, Mizrahi A, Golova A, Saretzky A,
Venzor AG, Slobodnik Z, Kaluski S, Einav M, Khrameeva E and Toiber
D: Aging and pathological aging signatures of the brain: Through
the focusing lens of SIRT6. Aging (Albany NY). 13:6420–6441. 2021.
View Article : Google Scholar
|
|
154
|
Smirnov D, Eremenko E, Stein D, Kaluski S,
Jasinska W, Cosentino C, Martinez-Pastor B, Brotman Y, Mostoslavsky
R, Khrameeva E and Toiber D: SIRT6 is a key regulator of
mitochondrial function in the brain. Cell Death Dis. 14:352023.
View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Ghio S, Kamp F, Cauchi R, Giese A and
Vassallo N: Interaction of α-synuclein with biomembranes in
Parkinson's disease-role of cardiolipin. Prog Lipid Res. 61:73–82.
2016. View Article : Google Scholar
|
|
156
|
Chu CT, Ji J, Dagda RK, Jiang JF, Tyurina
YY, Kapralov AA, Tyurin VA, Yanamala N, Shrivastava IH,
Mohammadyani D, et al: Cardiolipin externalization to the outer
mitochondrial membrane acts as an elimination signal for mitophagy
in neuronal cells. Nat Cell Biol. 15:1197–1205. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Doblado L, Lueck C, Rey C, Samhan-Arias
AK, Prieto I, Stacchiotti A and Monsalve M: Mitophagy in human
diseases. Int J Mol Sci. 22:39032021. View Article : Google Scholar :
|
|
158
|
Rocha EM, Smith GA, Park E, Cao H, Graham
AR, Brown E, McLean JR, Hayes MA, Beagan J, Izen SC, et al:
Sustained systemic glucocerebrosidase inhibition induces Brain
α-synuclein aggregation, microglia and complement C1q activation in
mice. Antioxid Redox Signal. 23:550–564. 2015. View Article : Google Scholar :
|
|
159
|
Sampson TR, Debelius JW, Thron T, Janssen
S, Shastri GG, Ilhan ZE, Challis C, Schretter CE, Rocha S,
Gradinaru V, et al: Gut microbiota regulate motor deficits and
neuroinflammation in a model of Parkinson's disease. Cell.
167:1469–1480.e12. 2016. View Article : Google Scholar
|
|
160
|
Mogi M, Harada M, Kondo T, Riederer P,
Inagaki H, Minami M and Nagatsu T: Interleukin-1 beta,
interleukin-6, epidermal growth factor and transforming growth
factor-alpha are elevated in the brain from parkinsonian patients.
Neurosci Lett. 180:147–150. 1994. View Article : Google Scholar
|
|
161
|
Moloney EB, Moskites A, Ferrari EJ,
Isacson O and Hallett PJ: The glycoprotein GPNMB is selectively
elevated in the substantia nigra of Parkinson's disease patients
and increases after lysosomal stress. Neurobiol Dis. 120:1–11.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Rebeck GW: The role of APOE on lipid
homeostasis and inflammation in normal brains. J Lipid Res.
58:1493–1499. 2017. View Article : Google Scholar
|
|
163
|
Atagi Y, Liu CC, Painter MM, Chen XF,
Verbeeck C, Zheng H, Li X, Rademakers R, Kang SS, Xu H, et al:
Apolipoprotein E is a ligand for triggering receptor expressed on
myeloid cells 2 (TREM2). J Biol Chem. 290:26043–26050. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Herrera AJ, Castano A, Venero JL, Cano J
and Machado A: The single intranigral injection of LPS as a new
model for studying the selective effects of inflammatory reactions
on dopaminergic system. Neurobiol Dis. 7:429–447. 2000. View Article : Google Scholar
|
|
165
|
Gao HM, Kotzbauer PT, Uryu K, Leight S,
Trojanowski JQ and Lee VM: Neuroinflammation and
oxidation/nitration of alpha-synuclein linked to dopaminergic
neurodegeneration. J Neurosci. 28:7687–7698. 2008. View Article : Google Scholar
|
|
166
|
Ioannou MS, Jackson J, Sheu SH, Chang CL,
Weigel AV, Liu H, Pasolli HA, Xu CS, Pang S, Matthies D, et al:
Neuron-astrocyte metabolic coupling protects against
Activity-induced fatty acid toxicity. Cell. 177:1522–1535.e14.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Braidy N, Gai WP, Xu YH, Sachdev P,
Guillemin GJ, Jiang XM, Ballard JW, Horan MP, Fang ZM, Chong BH and
Chan DK: Uptake and mitochondrial dysfunction of alpha-synuclein in
human astrocytes, cortical neurons and fibroblasts. Transl
Neurodegener. 2:202013. View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Sipione S, Rigamonti D, Valenza M, Zuccato
C, Conti L, Pritchard J, Kooperberg C, Olson JM and Cattaneo E:
Early transcriptional profiles in huntingtin-inducible striatal
cells by microarray analyses. Hum Mol Genet. 11:1953–1965. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Leoni V and Caccia C: Study of cholesterol
metabolism in Huntington's disease. Biochem Biophys Res Commun.
446:697–701. 2014. View Article : Google Scholar
|
|
170
|
Karasinska JM and Hayden MR: Cholesterol
metabolism in Huntington disease. Nat Rev Neurol. 7:561–572. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Leoni V and Caccia C: The impairment of
cholesterol metabolism in Huntington disease. Biochim Biophys Acta.
1851:1095–1105. 2015. View Article : Google Scholar
|
|
172
|
Valenza M, Rigamonti D, Goffredo D,
Zuccato C, Fenu S, Jamot L, Strand A, Tarditi A, Woodman B, Racchi
M, et al: Dysfunction of the cholesterol biosynthetic pathway in
Huntington's disease. J Neurosci. 25:9932–9939. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Wang N, Yvan-Charvet L, Lutjohann D,
Mulder M, Vanmierlo T, Kim TW and Tall AR: ATP-binding cassette
transporters G1 and G4 mediate cholesterol and desmosterol efflux
to HDL and regulate sterol accumulation in the brain. FASEB J.
22:1073–1082. 2008. View Article : Google Scholar
|
|
174
|
Leoni V, Long JD, Mills JA, Di Donato S
and Paulsen JS; PREDICT-HD study group: Plasma
24S-hydroxycholesterol correlation with markers of Huntington
disease progression. Neurobiol Dis. 55:37–43. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
175
|
Tansey TR and Shechter I: Squalene
synthase: Structure and regulation. Prog Nucleic Acid Res Mol Biol.
65:157–195. 2001. View Article : Google Scholar
|
|
176
|
Kreilaus F, Spiro AS, McLean CA, Garner B
and Jenner AM: Evidence for altered cholesterol metabolism in
Huntington's disease post mortem brain tissue. Neuropathol Appl
Neurobiol. 42:535–546. 2016. View Article : Google Scholar
|
|
177
|
Valenza M, Leoni V, Tarditi A, Mariotti C,
Bjorkhem I, Di Donato S and Cattaneo E: Progressive dysfunction of
the cholesterol biosynthesis pathway in the R6/2 mouse model of
Huntington's disease. Neurobiol Dis. 28:133–142. 2007. View Article : Google Scholar
|
|
178
|
Martin MG, Pfrieger F and Dotti CG:
Cholesterol in brain disease: Sometimes determinant and frequently
implicated. EMBO Rep. 15:1036–1052. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
179
|
Valenza M, Leoni V, Karasinska JM,
Petricca L, Fan J, Carroll J, Pouladi MA, Fossale E, Nguyen HP,
Riess O, et al: Cholesterol defect is marked across multiple rodent
models of Huntington's disease and is manifest in astrocytes. J
Neurosci. 30:10844–10850. 2010. View Article : Google Scholar
|
|
180
|
Xu Z, He S, Begum MM and Han X: Myelin
lipid alterations in neurodegenerative diseases: Landscape and
pathogenic implications. Antioxid Redox Signal. 41:1073–1099. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
181
|
Lawton KA, Brown MV, Alexander D, Li Z,
Wulff JE, Lawson R, Jaffa M, Milburn MV, Ryals JA, Bowser R, et al:
Plasma metabolomic biomarker panel to distinguish patients with
amyotrophic lateral sclerosis from disease mimics. Amyotroph
Lateral Scler Frontotemporal Degener. 15:362–370. 2014. View Article : Google Scholar
|
|
182
|
Goutman SA, Boss J, Guo K, Alakwaa FM,
Patterson A, Kim S, Savelieff MG, Hur J and Feldman EL: Untargeted
metabolomics yields insight into ALS disease mechanisms. J Neurol
Neurosurg Psychiatry. 91:1329–1338. 2020. View Article : Google Scholar
|
|
183
|
Sol J, Jove M, Povedano M, Sproviero W,
Dominguez R, Pinol-Ripoll G, Romero-Guevara R, Hye A, Al-Chalabi A,
Torres P, et al: Lipidomic traits of plasma and cerebrospinal fluid
in amyotrophic lateral sclerosis correlate with disease
progression. Brain Commun. 3:fcab1432021. View Article : Google Scholar : PubMed/NCBI
|
|
184
|
Area-Gomez E, Larrea D, Yun T, Xu Y, Hupf
J, Zandkarimi F, Chan RB and Mitsumoto H: Lipidomics study of
plasma from patients suggest that ALS and PLS are part of a
continuum of motor neuron disorders. Sci Rep. 11:135622021.
View Article : Google Scholar
|
|
185
|
FernAndez-Eulate G, Ruiz-Sanz JI, Riancho
J, ZufirIa M, GereNu G, FernAndez-TorrOn R, Poza-Aldea JJ, Ondaro
J, Espinal JB, GonzÁlez-ChinchÓn G, et al: A comprehensive serum
lipidome profiling of amyotrophic lateral sclerosis. Amyotroph
Lateral Scler Frontotemporal Degener. 21:252–262. 2020. View Article : Google Scholar
|
|
186
|
Winkler EA, Sengillo JD, Sullivan JS,
Henkel JS, Appel SH and Zlokovic BV: Blood-spinal cord barrier
breakdown and pericyte reductions in amyotrophic lateral sclerosis.
Acta Neuropathol. 125:111–120. 2013. View Article : Google Scholar
|
|
187
|
Waters S, Swanson MEV, Dieriks BV, Zhang
YB, Grimsey NL, Murray HC, Turner C, Waldvogel HJ, Faull RLM, An J,
et al: Blood-spinal cord barrier leakage is independent of motor
neuron pathology in ALS. Acta Neuropathol Commun. 9:1442021.
View Article : Google Scholar : PubMed/NCBI
|
|
188
|
Blasco H, Veyrat-Durebex C, Bocca C, Patin
F, Vourc'h P, Kouassi Nzoughet J, Lenaers G, Andres CR, Simard G,
Corcia P and Reynier P: Lipidomics reveals Cerebrospinal-Fluid
signatures of ALS. Sci Rep. 7:176522017. View Article : Google Scholar
|
|
189
|
Patin F, Corcia P, Vourc'h P,
Nadal-Desbarats L, Baranek T, Goossens JF, Marouillat S, Dessein
AF, Descat A, Madji Hounoum B, et al: Omics to explore amyotrophic
lateral sclerosis evolution: The central role of arginine and
proline metabolism. Mol Neurobiol. 54:5361–5374. 2017. View Article : Google Scholar
|
|
190
|
Cutler RG, Pedersen WA, Camandola S,
Rothstein JD and Mattson MP: Evidence that accumulation of
ceramides and cholesterol esters mediates oxidative Stress-induced
death of motor neurons in amyotrophic lateral sclerosis. Ann
Neurol. 52:448–457. 2002. View Article : Google Scholar
|
|
191
|
Dodge JC, Jensen EH, Yu J, Sardi SP,
Bialas AR, Taksir TV, Bangari DS and Shihabuddin LS: Neutral lipid
cacostasis contributes to disease pathogenesis in amyotrophic
lateral sclerosis. J Neurosci. 40:9137–9147. 2020. View Article : Google Scholar
|
|
192
|
Dodge JC, Treleaven CM, Pacheco J, Cooper
S, Bao C, Abraham M, Cromwell M, Sardi SP, Chuang WL, Sidman RL, et
al: Glycosphingolipids are modulators of disease pathogenesis in
amyotrophic lateral sclerosis. Proc Natl Acad Sci USA.
112:8100–8105. 2015. View Article : Google Scholar :
|
|
193
|
Burg T, Rossaert E, Moisse M, Van Damme P
and Van Den Bosch L: Histone deacetylase inhibition regulates lipid
homeostasis in a mouse model of amyotrophic lateral sclerosis. Int
J Mol Sci. 22:112242021. View Article : Google Scholar :
|
|
194
|
Chaves-Filho AB, Pinto IFD, Dantas LS,
Xavier AM, Inague A, Faria RL, Medeiros MHG, Glezer I, Yoshinaga MY
and Miyamoto S: Alterations in lipid metabolism of spinal cord
linked to amyotrophic lateral sclerosis. Sci Rep. 9:116422019.
View Article : Google Scholar :
|
|
195
|
Ramirez-Nunez O, Jove M, Torres P, Sol J,
Fontdevila L, Romero-Guevara R, Andres-Benito P, Ayala V, Rossi C,
Boada J, et al: Nuclear lipidome is altered in amyotrophic lateral
sclerosis: A pilot study. J Neurochem. 158:482–499. 2021.
View Article : Google Scholar
|
|
196
|
Johnson JO, Chia R, Miller DE, Li R,
Kumaran R, Abramzon Y, Alahmady N, Renton AE, Topp SD, Gibbs JR, et
al: Association of variants in the SPTLC1 gene with juvenile
amyotrophic lateral sclerosis. JAMA Neurol. 78:1236–1248. 2021.
View Article : Google Scholar
|
|
197
|
Mohassel P, Donkervoort S, Lone MA, Nalls
M, Gable K, Gupta SD, Foley AR, Hu Y, Saute JAM, Moreira AL, et al:
Childhood amyotrophic lateral sclerosis caused by excess
sphingolipid synthesis. Nat Med. 27:1197–1204. 2021. View Article : Google Scholar
|
|
198
|
Kim SM, Noh MY, Kim H, Cheon SY, Lee KM,
Lee J, Cha E, Park KS, Lee KW, Sung JJ and Kim SH:
25-Hydroxycholesterol is involved in the pathogenesis of
amyotrophic lateral sclerosis. Oncotarget. 8:11855–11867. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
199
|
Dodge JC, Yu J, Sardi SP and Shihabuddin
LS: Sterol auto-oxidation adversely affects human motor neuron
viability and is a neuropathological feature of amyotrophic lateral
sclerosis. Sci Rep. 11:8032021. View Article : Google Scholar : PubMed/NCBI
|
|
200
|
Kann O: The interneuron energy hypothesis:
Implications for brain disease. Neurobiol Dis. 90:75–85. 2016.
View Article : Google Scholar
|
|
201
|
Mauch DH, Nägler K, Schumacher S, Göritz
C, Müller EC, Otto A and Pfrieger FW: CNS synaptogenesis promoted
by Glia-derived cholesterol. Science. 294:1354–1357. 2001.
View Article : Google Scholar
|
|
202
|
Foley P: Lipids in Alzheimer's disease: A
century-old story. Biochim Biophys Acta. 1801:750–753. 2010.
View Article : Google Scholar
|
|
203
|
Cai XT, Li H, Borch Jensen M, Maksoud E,
Borneo J, Liang Y, Quake SR, Luo L, Haghighi P and Jasper H: Gut
cytokines modulate olfaction through metabolic reprogramming of
glia. Nature. 596:97–102. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
204
|
den Brok MH, Raaijmakers TK, Collado-Camps
E and Adema GJ: Lipid droplets as immune modulators in myeloid
cells. Trends Immunol. 39:380–392. 2018. View Article : Google Scholar
|
|
205
|
Lee JY, Marian OC and Don AS: Defective
lysosomal lipid catabolism as a common pathogenic mechanism for
dementia. Neuromolecular Med. 23:1–24. 2021. View Article : Google Scholar
|
|
206
|
Lin CH, Liao LY, Yang TY, Chang YJ, Tung
CW, Hsu SL and Hsueh CM: Microglia-derived adiposomes are potential
targets for the treatment of ischemic stroke. Cell Mol Neurobiol.
39:591–604. 2019. View Article : Google Scholar
|
|
207
|
Chali F, Milior G, Marty S, Morin-Brureau
M, Le Duigou C, Savary E, Blugeon C, Jourdren L and Miles R: Lipid
markers and related transcripts during excitotoxic
neurodegeneration in kainate-treated mice. Eur J Neurosci.
50:1759–1778. 2019. View Article : Google Scholar
|
|
208
|
Astarita G, Jung KM, Vasilevko V,
Dipatrizio NV, Martin SK, Cribbs DH, Head E, Cotman CW and Piomelli
D: Elevated stearoyl-CoA desaturase in brains of patients with
Alzheimer's disease. PLoS One. 6:e247772011. View Article : Google Scholar : PubMed/NCBI
|
|
209
|
Shibuya Y, Chang CC and Chang TY:
ACAT1/SOAT1 as a therapeutic target for Alzheimer's disease. Future
Med Chem. 7:2451–2467. 2015. View Article : Google Scholar
|
|
210
|
Lin YT, Seo J, Gao F, Feldman HM, Wen HL,
Penney J, Cam HP, Gjoneska E, Raja WK, Cheng J, et al: APOE4 causes
widespread molecular and cellular alterations associated with
Alzheimer's disease phenotypes in human iPSC-derived brain cell
types. Neuron. 98:1141–1154.e7. 2018. View Article : Google Scholar
|
|
211
|
Chen Y, Strickland MR, Soranno A and
Holtzman DM: Apolipoprotein E: Structural Insights and Links to
Alzheimer disease pathogenesis. Neuron. 109:205–221. 2021.
View Article : Google Scholar
|
|
212
|
Yen JHJ and Yu ICI: The role of
ApoE-mediated microglial lipid metabolism in brain aging and
disease. Immunometabolism (Cobham). 5:e000182023. View Article : Google Scholar
|
|
213
|
Sienski G, Narayan P, Bonner JM, Kory N,
Boland S, Arczewska AA, Ralvenius WT, Akay L, Lockshin E, He L, et
al: APOE4 disrupts intracellular lipid homeostasis in human
iPSC-derived glia. Sci Transl Med. 13:eaaz45642021. View Article : Google Scholar : PubMed/NCBI
|
|
214
|
Tcw J, Qian L, Pipalia NH, Chao MJ, Liang
SA, Shi Y, Jain BR, Bertelsen SE, Kapoor M, Marcora E, et al:
Cholesterol and matrisome pathways dysregulated in astrocytes and
microglia. Cell. 185:2213–2233.e25. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
215
|
Victor MB, Leary N, Luna X, Meharena HS,
Scannail AN, Bozzelli PL, Samaan G, Murdock MH, von Maydell D,
Effenberger AH, et al: Lipid accumulation induced by APOE4 impairs
microglial surveillance of neuronal-network activity. Cell Stem
Cell. 29:1197–1212.e8. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
216
|
Guglielmotto M, Monteleone D, Piras A,
Valsecchi V, Tropiano M, Ariano S, Fornaro M, Vercelli A, Puyal J,
Arancio O, et al: Aβ1-42 monomers or oligomers have different
effects on autophagy and apoptosis. Autophagy. 10:1827–1843. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
217
|
Baerends E, Soud K, Folke J, Pedersen AK,
Henmar S, Konrad L, Lycas MD, Mori Y, Pakkenberg B, Woldbye DPD, et
al: Modeling the early stages of Alzheimer's disease by
administering intracerebroventricular injections of human native Aβ
oligomers to rats. Acta Neuropathol Commun. 10:1132022. View Article : Google Scholar
|
|
218
|
Brown AJ and Jessup W: Oxysterols:
Sources, cellular storage and metabolism, and new insights into
their roles in cholesterol homeostasis. Mol Aspects Med.
30:111–122. 2009. View Article : Google Scholar
|
|
219
|
Chang JY, Chavis JA, Liu LZ and Drew PD:
Cholesterol oxides induce programmed cell death in microglial
cells. Biochem Biophys Res Commun. 249:817–821. 1998. View Article : Google Scholar
|
|
220
|
Liu J, Liu Y, Chen J, Hu C, Teng M, Jiao
K, Shen Z, Zhu D, Yue J, Li Z and Li Y: The ROS-mediated activation
of IL-6/STAT3 signaling pathway is involved in the
27-hydroxycholesterol-induced cellular senescence in nerve cells.
Toxicol In Vitro. 45:10–18. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
221
|
Simpson DSA and Oliver PL: ROS Generation
in microglia: Understanding oxidative stress and inflammation in
neurodegenerative disease. Antioxidants (Basel). 9:7432020.
View Article : Google Scholar : PubMed/NCBI
|
|
222
|
Olsen BN, Schlesinger PH and Baker NA:
Perturbations of membrane structure by cholesterol and cholesterol
derivatives are determined by sterol orientation. J Am Chem Soc.
131:4854–4865. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
223
|
Kauffman JM, Westerman PW and Carey MC:
Fluorocholesterols, in contrast to hydroxycholesterols, exhibit
interfacial properties similar to cholesterol. J Lipid Res.
41:991–1003. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
224
|
Appelqvist H, Wäster P, Kågedal K and
Öllinger K: The lysosome: From waste bag to potential therapeutic
target. J Mol Cell Biol. 5:214–226. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
225
|
Gosselet F, Saint-Pol J and Fenart L:
Effects of oxysterols on the blood-brain barrier: Implications for
Alzheimer's disease. Biochem Biophys Res Commun. 446:687–691. 2014.
View Article : Google Scholar
|
|
226
|
Trompier D, Vejux A, Zarrouk A, Gondcaille
C, Geillon F, Nury T, Savary S and Lizard G: Brain peroxisomes.
Biochimie. 98:102–110. 2014. View Article : Google Scholar
|
|
227
|
Loving BA, Tang M, Neal MC, Gorkhali S,
Murphy R, Eckel RH and Bruce KD: Lipoprotein lipase regulates
microglial lipid droplet accumulation. Cells. 10:1982021.
View Article : Google Scholar
|
|
228
|
Berghoff SA, Spieth L, Sun T, Hosang L,
Schlaphoff L, Depp C, Düking T, Winchenbach J, Neuber J, Ewers D,
et al: Microglia facilitate repair of demyelinated lesions via
Post-squalene sterol synthesis. Nat Neurosci. 24:47–60. 2021.
View Article : Google Scholar :
|
|
229
|
Ciesielska A, Matyjek M and Kwiatkowska K:
TLR4 and CD14 trafficking and its influence on LPS-induced
Pro-inflammatory signaling. Cell Mol Life Sci. 78:1233–1261. 2021.
View Article : Google Scholar
|
|
230
|
Sheng JG, Bora SH, Xu G, Borchelt DR,
Price DL and Koliatsos VE:
Lipopolysaccharide-Induced-neuroinflammation increases
intracellular accumulation of amyloid precursor protein and amyloid
beta peptide in APPswe transgenic mice. Neurobiol Dis. 14:133–145.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
231
|
Chen Y, Yin M, Cao X, Hu G and Xiao M:
Pro- and Anti-inflammatory effects of high cholesterol diet on aged
brain. Aging Dis. 9:374–390. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
232
|
Iannucci J, Sen A and Grammas P:
Isoform-specific effects of apolipoprotein E on markers of
inflammation and toxicity in brain glia and neuronal cells in
vitro. Curr Issues Mol Biol. 43:215–225. 2021. View Article : Google Scholar
|
|
233
|
Churchward MA and Todd KG: Statin
treatment affects cytokine release and phagocytic activity in
primary cultured microglia through two separable mechanisms. Mol
Brain. 7:852014. View Article : Google Scholar : PubMed/NCBI
|
|
234
|
Tanaka N, Abe-Dohmae S, Iwamoto N,
Fitzgerald ML and Yokoyama S: Helical apolipoproteins of
High-density lipoprotein enhance phagocytosis by stabilizing
ATP-binding cassette transporter A7. J Lipid Res. 51:2591–2599.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
235
|
Aikawa T, Holm ML and Kanekiyo T: ABCA7
and pathogenic pathways of Alzheimer's disease. Brain Sci.
8:272018. View Article : Google Scholar : PubMed/NCBI
|
|
236
|
Dai W, Yao RM, Mi TY, Zhang LM, Wu HL,
Cheng JB and Li YF: Cognition-enhancing effect of YL-IPA08, a
potent ligand for the translocator protein (18 kDa) in the 5 x FAD
transgenic mouse model of Alzheimer's pathology. J Psychopharmacol.
36:1176–1187. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
237
|
Bouhrara M, Reiter DA, Bergeron CM, Zukley
LM, Ferrucci L, Resnick SM and Spencer RG: Evidence of
demyelination in mild cognitive impairment and dementia using a
direct and specific magnetic resonance imaging measure of myelin
content. Alzheimers Dement. 14:998–1004. 2018. View Article : Google Scholar
|
|
238
|
Benitez A, Fieremans E, Jensen JH,
Falangola MF, Tabesh A, Ferris SH and Helpern JA: White matter
tract integrity metrics reflect the vulnerability of
Late-myelinating tracts in Alzheimer's disease. Neuroimage Clin.
4:64–71. 2014. View Article : Google Scholar
|
|
239
|
Depp C, Sun T, Sasmita AO, Spieth L,
Berghoff SA, Nazarenko T, Overhoff K, Steixner-Kumar AA,
Subramanian S, Arinrad S, et al: Myelin dysfunction drives
amyloid-β deposition in models of Alzheimer's disease. Nature.
618:349–357. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
240
|
Mathys H, Davila-Velderrain J, Peng Z, Gao
F, Mohammadi S, Young JZ, Menon M, He L, Abdurrob F, Jiang X, et
al: Single-cell transcriptomic analysis of Alzheimer's disease.
Nature. 570:332–337. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
241
|
Saez-Atienzar S and Masliah E: Cellular
senescence and Alzheimer disease: The egg and the chicken scenario.
Nat Rev Neurosci. 21:433–444. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
242
|
Lloyd AF and Miron VE: The
Pro-remyelination properties of microglia in the central nervous
system. Nat Rev Neurol. 15:447–458. 2019. View Article : Google Scholar
|
|
243
|
Cignarella F, Filipello F, Bollman B,
Cantoni C, Locca A, Mikesell R, Manis M, Ibrahim A, Deng L, Benitez
BA, et al: TREM2 activation on microglia promotes myelin debris
clearance and remyelination in a model of multiple sclerosis. Acta
Neuropathol. 140:513–534. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
244
|
Miron VE, Boyd A, Zhao JW, Yuen TJ, Ruckh
JM, Shadrach JL, van Wijngaarden P, Wagers AJ, Williams A, Franklin
RJM, et al: M2 microglia and macrophages drive oligodendrocyte
differentiation during CNS remyelination. Nat Neurosci.
16:1211–1218. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
245
|
Lloyd AF, Davies CL, Holloway RK, Labrak
Y, Ireland G, Carradori D, Dillenburg A, Borger E, Soong D,
Richardson JC, et al: Central nervous system regeneration is driven
by microglia necroptosis and repopulation. Nat Neurosci.
22:1046–1052. 2019. View Article : Google Scholar :
|
|
246
|
Mecha M, Yanguas-Casás N, Feliú A, Mestre
L, Carrillo-Salinas F, Azcoitia I, Yong VW and Guaza C: The
endocannabinoid 2-AG enhances spontaneous remyelination by
targeting microglia. Brain Behav Immun. 77:110–126. 2019.
View Article : Google Scholar
|
|
247
|
Wang X, Cao K, Sun X, Chen Y, Duan Z, Sun
L, Guo L, Bai P, Sun D, Fan J, et al: Macrophages in spinal cord
injury: Phenotypic and functional change from exposure to myelin
debris. Glia. 63:635–651. 2015. View Article : Google Scholar :
|
|
248
|
Mrdjen D, Pavlovic A, Hartmann FJ,
Schreiner B, Utz SG, Leung BP, Lelios I, Heppner FL, Kipnis J,
Merkler D, et al: High-Dimensional Single-cell mapping of central
nervous system immune cells reveals distinct myeloid subsets in
health, aging, and disease. Immunity. 48:5992018. View Article : Google Scholar
|
|
249
|
Hammond TR, Dufort C, Dissing-Olesen L,
Giera S, Young A, Wysoker A, Walker AJ, Gergits F, Segel M, Nemesh
J, et al: Single-Cell RNA sequencing of microglia throughout the
mouse lifespan and in the injured brain reveals complex cell-state
changes. Immunity. 50:253–271.e6. 2019. View Article : Google Scholar
|
|
250
|
Zrzavy T, Hametner S, Wimmer I, Butovsky
O, Weiner HL and Lassmann H: Loss of 'homeostatic' microglia and
patterns of their activation in active multiple sclerosis. Brain.
140:1900–1913. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
251
|
Locatelli G, Theodorou D, Kendirli A,
Jordão MJC, Staszewski O, Phulphagar K, Cantuti-Castelvetri L,
Dagkalis A, Bessis A, Simons M, et al: Mononuclear phagocytes
locally specify and adapt their phenotype in a multiple sclerosis
model. Nat Neurosci. 21:1196–1208. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
252
|
Wlodarczyk A, Benmamar-Badel A, Cédile O,
Jensen KN, Kramer I, Elsborg NB and Owens T: CSF1R stimulation
promotes increased neuroprotection by CD11c+ microglia in EAE.
Front Cell Neurosci. 12:5232018. View Article : Google Scholar
|
|
253
|
Yu Z, Sun D, Feng J, Tan W, Fang X, Zhao
M, Zhao X, Pu Y, Huang A, Xiang Z, et al: MSX3 Switches microglia
polarization and protects from Inflammation-induced demyelination.
J Neurosci. 35:6350–6365. 2015. View Article : Google Scholar
|
|
254
|
Zabala A, Vazquez-Villoldo N, Rissiek B,
Gejo J, Martin A, Palomino A, Perez-Samartín A, Pulagam KR,
Lukowiak M, Capetillo-Zarate E, et al: P2X4 receptor controls
microglia activation and favors remyelination in autoimmune
encephalitis. EMBO Mol Med. 10:e87432018. View Article : Google Scholar :
|
|
255
|
Brüne B, Dehne N, Grossmann N, Jung M,
Namgaladze D, Schmid T, von Knethen A and Weigert A: Redox control
of inflammation in macrophages. Antioxid Redox Signal. 19:595–637.
2013. View Article : Google Scholar
|
|
256
|
Conrad M, Kagan VE, Bayir H, Pagnussat GC,
Head B, Traber MG and Stockwell BR: Regulation of lipid
peroxidation and ferroptosis in diverse species. Genes Dev.
32:602–619. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
257
|
Wenzel SE, Tyurina YY, Zhao J, St Croix
CM, Dar HH, Mao G, Tyurin VA, Anthonymuthu TS, Kapralov AA,
Amoscato AA, et al: PEBP1 wardens ferroptosis by enabling
lipoxygenase generation of lipid death signals. Cell.
171:628–641.e26. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
258
|
Kagan VE, Mao G, Qu F, Angeli JP, Doll S,
Croix CS, Dar HH, Liu B, Tyurin VA, Ritov VB, et al: Oxidized
arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem
Biol. 13:81–90. 2017. View Article : Google Scholar
|
|
259
|
Anthonymuthu TS, Kenny EM, Shrivastava I,
Tyurina YY, Hier ZE, Ting HC, Dar HH, Tyurin VA, Nesterova A,
Amoscato AA, et al: Empowerment of 15-lipoxygenase catalytic
competence in selective oxidation of membrane ETE-PE to ferroptotic
death signals, HpETE-PE. J Am Chem Soc. 140:17835–17839. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
260
|
Kapralov AA, Yang Q, Dar HH, Tyurina YY,
Anthonymuthu TS, Kim R, St Croix CM, Mikulska-Ruminska K, Liu B,
Shrivastava IH, et al: Redox lipid reprogramming commands
susceptibility of macrophages and microglia to ferroptotic death.
Nat Chem Biol. 16:278–290. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
261
|
Doll S, Proneth B, Tyurina YY, Panzilius
E, Kobayashi S, Ingold I, Irmler M, Beckers J, Aichler M, Walch A,
et al: ACSL4 dictates ferroptosis sensitivity by shaping cellular
lipid composition. Nat Chem Biol. 13:91–98. 2017. View Article : Google Scholar
|
|
262
|
Zhou Y, Yang Y, Yi L, Pan M, Tang W and
Duan H: Propofol mitigates Sepsis-induced brain injury by
inhibiting ferroptosis via activation of the Nrf2/HO-1axis.
Neurochem Res. 49:2131–2147. 2024. View Article : Google Scholar
|
|
263
|
Zhou X, Zhao R, Lv M, Xu X, Liu W, Li X,
Gao Y, Zhao Z, Zhang Z, Li Y, et al: ACSL4 promotes
microgliamediated neuroinflammation by regulating lipid metabolism
and VGLL4 expression. Brain Behav Immun. 109:331–343. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
264
|
Liang D, Minikes AM and Jiang X:
Ferroptosis at the intersection of lipid metabolism and cellular
signaling. Mol Cell. 82:2215–2227. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
265
|
Wu H, Li N, Peng S, Fu H, Hu Z and Su L:
Maresin1 improves hippocampal neuroinflammation and cognitive
function in septic rats by activating the SLC7A11/GPX4 ferroptosis
signaling pathway. Int Immunopharmacol. 131:1117922024. View Article : Google Scholar
|
|
266
|
Fernández-Mendívil C, Luengo E,
Trigo-Alonso P, García-Magro N, Negredo P and López MG: Protective
role of microglial HO-1 blockade in aging: Implication of iron
metabolism. Redox Biol. 38:1017892021. View Article : Google Scholar
|
|
267
|
Gao S, Zhou L, Lu J, Fang Y, Wu H, Xu W,
Pan Y, Wang J, Wang X, Zhang J and Shao A: Cepharanthine attenuates
early brain injury after subarachnoid hemorrhage in mice via
inhibiting 15-Lipoxygenase-1-Mediated microglia and endothelial
cell ferroptosis. Oxid Med Cell Longev. 2022:42952082022.
View Article : Google Scholar :
|
|
268
|
Strike SC, Carlisle A, Gibson EL and Dyall
SC: A High Omega-3 fatty acid multinutrient supplement benefits
cognition and mobility in older women: A randomized, Double-blind,
Placebo-controlled pilot study. J Gerontol A Biol Sci Med Sci.
71:236–242. 2016. View Article : Google Scholar
|
|
269
|
Lee LK, Shahar S, Chin AV and Yusoff NA:
Docosahexaenoic Acid-concentrated fish oil supplementation in
subjects with mild cognitive impairment (MCI): A 12-month
randomised, double-blind, placebo-controlled trial.
Psychopharmacology (Berl). 225:605–612. 2013. View Article : Google Scholar
|
|
270
|
Serrano-Pozo A, Vega GL, Lütjohann D,
Locascio JJ, Tennis MK, Deng A, Atri A, Hyman BT, Irizarry MC and
Growdon JH: Effects of simvastatin on cholesterol metabolism and
Alzheimer disease biomarkers. Alzheimer Dis Assoc Disord.
24:220–226. 2010. View Article : Google Scholar
|
|
271
|
Evans BA, Evans JE, Baker SP, Kane K,
Swearer J, Hinerfeld D, Caselli R, Rogaeva E, St George-Hyslop P,
Moonis M and Pollen DA: Long-term statin therapy and CSF
cholesterol levels: Implications for Alzheimer's disease. Dement
Geriatr Cogn Disord. 27:519–524. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
272
|
Qin Z, Gu M, Zhou J, Zhang W, Zhao N, Lü Y
and Yu W: Triggering receptor expressed on myeloid cells 2
activation downregulates toll-like receptor 4 expression and
ameliorates cognitive impairment in the Aβ1-42-induced Alzheimer's
disease mouse model. Synapse. 74:e221612020. View Article : Google Scholar
|
|
273
|
Price BR, Sudduth TL, Weekman EM, Johnson
S, Hawthorne D, Woolums A and Wilcock DM: Therapeutic Trem2
activation ameliorates amyloid-beta deposition and improves
cognition in the 5XFAD model of amyloid deposition. J
Neuroinflammation. 17:2382020. View Article : Google Scholar : PubMed/NCBI
|
|
274
|
Fitz NF, Nam KN, Wolfe CM, Letronne F,
Playso BE, Iordanova BE, Kozai TDY, Biedrzycki RJ, Kagan VE,
Tyurina YY, et al: Phospholipids of APOE lipoproteins activate
microglia in an Isoform-specific manner in preclinical models of
Alzheimer's disease. Nat Commun. 12:34162021. View Article : Google Scholar : PubMed/NCBI
|
|
275
|
Griciuc A, Patel S, Federico AN, Choi SH,
Innes BJ, Oram MK, Cereghetti G, McGinty D, Anselmo A, Sadreyev RI,
et al: TREM2 Acts downstream of CD33 in modulating microglial
pathology in Alzheimer's disease. Neuron. 103:820–835.e827. 2019.
View Article : Google Scholar
|
|
276
|
Lefterov I, Schug J, Mounier A, Nam KN,
Fitz NF and Koldamova R: RNA-sequencing reveals transcriptional
up-regulation of Trem2 in response to bexarotene treatment.
Neurobiol Dis. 82:132–140. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
277
|
Tai LM, Koster KP, Luo J, Lee SH, Wang YT,
Collins NC, Ben Aissa M, Thatcher GRJ and LaDu MJ: Amyloid-β
pathology and APOE genotype modulate retinoid X receptor agonist
activity in vivo. J Biol Chem. 289:30538–30555. 2014. View Article : Google Scholar :
|
|
278
|
Khan N, Syed DN, Ahmad N and Mukhtar H:
Fisetin: A dietary antioxidant for health promotion. Antioxid Redox
Signal. 19:151–162. 2013. View Article : Google Scholar :
|
|
279
|
Prior M, Chiruta C, Currais A, Goldberg J,
Ramsey J, Dargusch R, Maher PA and Schubert D: Back to the future
with phenotypic screening. ACS Chem Neurosci. 5:503–513. 2014.
View Article : Google Scholar
|
|
280
|
Ates G, Goldberg J, Currais A and Maher P:
CMS121, a fatty acid synthase inhibitor, protects against excess
lipid peroxidation and inflammation and alleviates cognitive loss
in a transgenic mouse model of Alzheimer's disease. Redox Biol.
36:1016482020. View Article : Google Scholar : PubMed/NCBI
|
|
281
|
Ayala A, Muñoz MF and Argüelles S: Lipid
peroxidation: Production, metabolism, and signaling mechanisms of
malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev.
2014:3604382014. View Article : Google Scholar : PubMed/NCBI
|
|
282
|
Oostveen JA, Dunn E, Carter DB and Hall
ED: Neuroprotective efficacy and mechanisms of novel
pyrrolopyrimidine lipid peroxidation inhibitors in the gerbil
forebrain ischemia model. J Cereb Blood Flow Metab. 18:539–547.
1998. View Article : Google Scholar
|
